Sphere Fluidics has announced it is rebranding to Sphere Bio to reflect the company’s transition from a focus on droplet-based microfluidics to a provider of integrated life sciences tools and solutions. Founded in 2010, the company has been focused on the development of novel single-cell analysis products and R&D services for a growing portfolio of […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!